Cargando…

Low radiotherapy dose is suitable for brain metastases in SCLC compared with high dose

OBJECTIVE: This study was designed to evaluate the suitable radiotherapy dose in SCLC patients with BM. METHODS: A retrospective analysis was performed among 121 patients on the prognosis of BM of SCLC who were admitted to our hospital from 2013 to 2023. They all received first line chemotherapy. 80...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Liming, Zhang, Kunning, Han, Haonan, Sun, Han, Yuan, Yajing, Wang, Jun, Zhao, Lujun, Wang, Ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10541991/ https://www.ncbi.nlm.nih.gov/pubmed/37786509 http://dx.doi.org/10.3389/fonc.2023.1245506

Ejemplares similares

A novel approach for dose painting radiotherapy of brain metastases guided by mr perfusion images
por: Hou, Chuanke, et al.
Publicado: (2022)

Optimizing Whole Brain Radiotherapy Treatment and Dose for Patients With Brain Metastases From Small Cell Lung Cancer
por: Li, Hanming, et al.
Publicado: (2021)

Low-Dose Radiotherapy Versus Moderate-Dose Radiotherapy for the Treatment of Indolent Orbital Adnexal Lymphomas
por: Baron, Jonathan, et al.
Publicado: (2021)

Organoids as a Systems Platform for SCLC Brain Metastasis
por: Quaranta, Vito, et al.
Publicado: (2022)

Study of peripheral dose from low-dose CT to adaptive radiotherapy of postoperative prostate cancer
por: Gan, Guanghui, et al.
Publicado: (2023)

Improving stereotactic radiotherapy (SRT) planning process for brain metastases by Cyberknife system: reducing dose distribution in healthy tissues
por: Xuyao, Yu, et al.
Publicado: (2020)

Significance of low-dose radiation distribution in development of radiation pneumonitis after helical-tomotherapy-based hypofractionated radiotherapy for pulmonary metastases
por: Jo, In-Young, et al.
Publicado: (2014)

Key changes in the future clinical application of ultra-high dose rate radiotherapy
por: Lin, Binwei, et al.
Publicado: (2023)

The Cognitive Effects of Radiotherapy for Brain Metastases
por: Lehrer, Eric J., et al.
Publicado: (2022)

Clinical outcomes of salvage radiotherapy in patients with supraclavicular lymph node metastases after esophagectomy
por: Ping, Zhang, et al.
Publicado: (2023)

Platelet Membranes Coated Gold Nanocages for Tumor Targeted Drug Delivery and Amplificated Low-Dose Radiotherapy
por: Chen, Mingzhu, et al.
Publicado: (2021)

Whole brain radiation therapy plus focal boost may be a suitable strategy for brain metastases in SCLC patients: a multi-center study
por: Ni, Meng, et al.
Publicado: (2020)

Evaluation of Biological Effective Dose in Gamma Knife Staged Stereotactic Radiosurgery for Large Brain Metastases
por: Cui, Taoran, et al.
Publicado: (2022)

Pretreatment lymphocyte-to-monocyte ratio as a prognostic factor and influence on dose-effect in fractionated stereotactic radiotherapy for oligometastatic brain metastases in non-small cell lung cancer patients
por: Chen, Tian, et al.
Publicado: (2023)

Intermediate Dose-Volume Parameters, Not Low-Dose Bath, Is Superior to Predict Radiation Pneumonitis for Lung Cancer Treated With Intensity-Modulated Radiotherapy
por: Meng, Yinnan, et al.
Publicado: (2020)

Optimal dose-fractionation schedule of palliative radiotherapy for patients with bone metastases: a protocol for systematic review and network meta-analysis
por: Tang, Xiaofang, et al.
Publicado: (2020)

Dose-Response Effect and Dose-Toxicity in Stereotactic Radiotherapy for Brain Metastases: A Review
por: Loo, Maxime, et al.
Publicado: (2021)

The anti-tumor efficiency of low-dose apatinib-based chemotherapy in pretreated HER2-negative breast cancer with brain metastases
por: Chen, Xuelian, et al.
Publicado: (2023)

Is De-escalated Bisphosphonates Therapy a Suitable Alternative to Standard Dosing in Malignant Tumor Patients With Bone Metastases: A Systematic Review and Meta-Analysis
por: Luo, Qiuhua, et al.
Publicado: (2019)

Clinical Response to Apatinib Combined With Brain Radiotherapy in EGFR Wild-Type and ALK-Negative Lung Adenocarcinoma With Multiple Brain Metastases
por: Ying, Xiaofang, et al.
Publicado: (2020)

Deep learning-based low-dose CT for adaptive radiotherapy of abdominal and pelvic tumors
por: Gong, Wei, et al.
Publicado: (2022)

Radiotherapy and the Tumor Stroma: The Importance of Dose and Fractionation
por: Hellevik, Turid, et al.
Publicado: (2014)

Esophageal Cancer Radiotherapy Dose Escalation Meta Regression Commentary: “High vs. Low Radiation Dose of Concurrent Chemoradiotherapy for Esophageal Carcinoma With Modern Radiotherapy Techniques: A Meta-Analysis”
por: Chow, Ronald, et al.
Publicado: (2021)

Dose-effect relationship of linear accelerator based stereotactic radiotherapy for brain metastases
por: Wu, Ning, et al.
Publicado: (2023)

Comparative analysis of dose calculation algorithms for CyberKnife-based stereotactic radiotherapy in lung cancer
por: Ge, Xuanchu, et al.
Publicado: (2023)

High vs. Low Radiation Dose of Concurrent Chemoradiotherapy for Esophageal Carcinoma With Modern Radiotherapy Techniques: A Meta-Analysis
por: Sun, Xin, et al.
Publicado: (2020)

Five-fraction CyberKnife radiotherapy for large brain metastases in critical areas: impact on the surrounding brain volumes circumscribed with a single dose equivalent of 14 Gy (V14) to avoid radiation necrosis
por: Inoue, Hiroshi K., et al.
Publicado: (2014)

Three-fraction CyberKnife radiotherapy for brain metastases in critical areas: referring to the risk evaluating radiation necrosis and the surrounding brain volumes circumscribed with a single dose equivalence of 14 Gy (V14)
por: Inoue, Hiroshi K., et al.
Publicado: (2013)

Update on the Biology, Management, and Treatment of Small Cell Lung Cancer (SCLC)
por: Saltos, Andreas, et al.
Publicado: (2020)

SCLC Treatment in the Immuno-Oncology Era: Current Evidence and Unmet Needs
por: Belluomini, Lorenzo, et al.
Publicado: (2022)

Survival, Chemotherapy and Chemosensitivity Predicted by CTC Cultured In Vitro of SCLC Patients
por: Ju, Lixia, et al.
Publicado: (2021)

Editorial: Precision medicine approaches in radiotherapy and systemic therapy of brain metastases
por: Kaul, David, et al.
Publicado: (2023)

Risk Prediction Model for Synchronous Oligometastatic Non-Small Cell Lung Cancer: Thoracic Radiotherapy May Not Prolong Survival in High-Risk patients
por: Meng, Chunliu, et al.
Publicado: (2022)

Combined effect of dose gradient and rotational error on prescribed dose coverage for single isocenter multiple brain metastases in frameless stereotactic radiotherapy
por: Yoon, Jai-Woong, et al.
Publicado: (2021)

Comparison of whole brain radiation therapy for synchronous brain metastases with irradiation protecting the hippocampus versus whole brain radiotherapy for sequential brain metastases to boost irradiation in the treatment of brain metastases from SCLC: study protocol for a randomized controlled trial
por: Zhang, Xiaofang, et al.
Publicado: (2022)

How many brain metastases can be treated with stereotactic radiosurgery before the radiation dose delivered to normal brain tissue rivals that associated with standard whole brain radiotherapy?
por: Becker, Stewart J., et al.
Publicado: (2023)

Boosting radiotherapy dose calculation accuracy with deep learning
por: Xing, Yixun, et al.
Publicado: (2020)

Case report: Fractional brain tumor burden magnetic resonance mapping to assess response to pulsed low-dose-rate radiotherapy in newly-diagnosed glioblastoma
por: Amidon, Ryan F., et al.
Publicado: (2022)

Challenges of Using High-Dose Fractionation Radiotherapy in Combination Therapy
por: Yang, Ying-Chieh, et al.
Publicado: (2016)

Construction and Verification of Nomogram Model for Lung Adenocarcinoma With ≤ 5 Bone-Only Metastases Basing on Hematology Markers
por: Meng, Chunliu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2tugb45466aq7j13jooeatft24